|
| |
Gaviscon, Liquidum - 200 ml | | 42237019 | | NOVARTIS CONSUMER HEALTH SCHWEIZ AG | | Gaviscon, Liquidum | | 09.07.1980 | | | | | | Antacids, Other Combinations (A02AX) | | | | WHO-DDD | | | | | | 200 ml | | | | | | D | | | | No | | | | | | CI | | PR | | | | k.A. | | 12.90 | | FB | | | | 7680422370191 | | | | | | |
| Composition | | Packungsbestandteile | | Suspension (oral) | | Active Agent | Dose |
---|
Aluminii Oxidum Hydricum | 200 mg | Calcium Carbonate | 150 mg | Sodium Alginate | 500 mg | Sodium Hydrogen Carbonate | 170 mg |
|
| Source | |
|
|
|